Stay up to date with news from OSI and our portfolio

Welcome to the portfolio Ivy Farm Technologies! Find out why Ivy Farm is the future for meat lovers, animal lovers and our planet.

Read more

First Light Fusion installs UK’s biggest two-stage hyper-velocity gas gun to advance its projectile fusion technology.

Read more

Perspectum partners in a new study in singapore for the early detection of liver cancer using precision medicine

Read more

Vaccitech announces closing of $110.5 million initial public offering – the 1st IPO for the OSI portfolio!

Read more

Vaccitech announces pricing of initial public offering – the 1st IPO for the OSI portfolio!

Read more

Perspectum’s new study shows measurable organ impairment in Long COVID patients

Read more

Alexis Dormandy has joined the UK government’s new expert council formed to maximise UK investment offer

Read more

OSI UPDATES: SPRING 2021 NEWSLETTER

Read more

Oxford Endovascular Ltd raises $10m to develop its origami engineered medical device to prevent brain haemorrhage

Read more

Quantum Computing Breakthrough Shows Blueprint for Scalable Future

Read more

Perspectum research links high liver fat to increased risk of hospitalization in COVID-19 patients with obesity

Read more

Meet the Founders: Cheerag Shirodaria, CEO and Charalambos Antoniades, CSO, Caristo Diagnostics

Read more

Caristo Diagnostics announces EU approval for AI technology which can predict heart attacks years in advance

Read more

Vaccitech appoints Joseph Scheeren, PharmD, to its Board of Directors

Read more

Vaccitech Doses First Patient in HPV001, a Phase 1/2 Clinical Trial of VTP-200 Immunotherapeutic for High-risk Persistent HPV Infection

Read more

Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results

Read more

Meet Oxford’s Female Founders & CEOs – watch the recorded event!

Read more

International Women’s Day: Meet Oxford’s Female Founders

Read more

SpyBiotech announces the appointments of Dan Menichella as Non-Executive Director and Dr Norman Begg as Scientific Advisor

Read more

MoA Tech appoints Virginia Corless as CEO

Read more

Perspectum Lands Top Spot in Alantra Pharma Fast 50 Rankings

Read more

Vaccitech appoints two independent board directors

Read more

Genomics Plc completes oversubscribed $30m funding round

Read more

PepGen Announces Formation of Scientific Advisory Board

Read more

Welcome to the portfolio: T-Cypher Bio

Read more

EVOX THERAPEUTICS COMPLETES £69.2 MILLION SERIES C FINANCING

Read more

£2.5M for intelligent battery technology start up, Brill Power

Read more

SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman

Read more

OSI UPDATES: WINTER 2021 NEWSLETTER

Read more

Professor Jerry Chittenden joins First Light Fusion’s Advisory Board

Read more

PepGen appoints James McArthur, Ph.D., as President and Chief Executive Officer

Read more

Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman

Read more

First patient receives Vaccitech’s VTP-300 in a Phase 1b/2a clinical trial. An experimental immunotherapy for chronic HBV, a global health problem affecting over 250 million people

Read more

Introducing our first Entrepreneur in Residence from Biopharma: Damian Crowther

Read more

John McHutchison joins the board of Evox Therapeutics

Read more

Perspectum’s CoverScan MD approved by the UK’s MHRA – the world’s first integrated imaging service capable of mapping the impact of COVID-19 on the body

Read more

Ex-Centrica and BP boss Iain Conn joins Oxford Flow board

Read more

OQC lab takes delivery of first Proteox worldwide – a significant milestone to building a quantum-powered future

Read more

OQC state-of-the-art quantum laboratory opens

Read more

Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies

Read more

Ultromics’ first-of-a-kind AI solution to help clinicians diagnose coronary artery disease from echiocardiograms in a matter of minutes approved by the FDA

Read more

Bodle Technologies Secures Series A Funding Extension

Read more

Perspectum issued CPT® Codes for LiverMultiScan® by the American Medical Association to help Drs diagnose and treat liver disease

Read more

Clean nuclear: Oxford start-up 10 years ahead of government targets in race to build fusion plant

Read more

LifeArc co-leads £6 million funding in DJS Antibodies

Read more

MERRY CHRISTMAS FROM ALL THE TEAM AT OSI

Read more

Meet the Founder: Sumi Biswas, CEO of SpyBiotech

Read more

PepGen raises $45M in Series A funding, led by RA Capital

Read more

HEXR launches smartphone fitting app: Bespoke, 3D printed helmets now accessible to millions

Read more

Software Ate the World, and Soon It Will Write Itself – Wall Street Journal article by Diffblue

Read more

Counterfeit drugs and illegitimate vaccines, both costly and deadly, could be a thing of the past with new breakthrough testing technology from Proxisense and Oxford University

Read more

Refeyn Closes Series A Funding Round, led by Northpond Ventures

Read more

The Backstory: Vaccitech and its role in co-inventing the Oxford COVID-19 vaccine

Read more

BREAKTHROUGH FOR OXFORD’S COVID VACCINE, CO-INVENTED BY OSI PORTFOLIO COMPANY VACCITECH

Read more

Evox Therapeutics launch strategic collaboration with Oxford University to accelerate development of exosome therapies for rare diseases

Read more

Mind Foundry raises an additional $13.6 million in Series A funding led by Aioi Nissay Dowa Insurance

Read more

OSI UPDATES: AUTUMN 2020 NEWSLETTER

Read more

The Backstory: Base Genomics and their mission to defeat cancer through early diagnosis

Read more

Oxford Sciences Innovation announces the sale of Base Genomics to Exact Sciences

Read more

Vaccitech expands management team with hires including CMO and CFO

Read more

Notice of Annual General Meeting

Read more

Fusion energy can be the most cost competitive source of baseload power, at the same level as renewables

Read more

Oxford Sciences Innovation appoints Alexis Dormandy as CEO

Read more

Scenic Biotech Enters into Genetic Modifier Collaboration with Genentech

Read more

3 portfolio companies win the NHSX AI in Healthcare Award

Read more

SpyBiotech and Serum Institute of India announce that the first subjects have been dosed in a Phase I/II trial of a novel virus-like particle vaccine targeting COVID-19

Read more

Biocentury feature: OSI leverages foundational deal with Oxford to build its life sciences portfolio

Read more

Celebrating five years of OSI and Oxford’s history of innovation

Read more

Meet the Founder: Ilana Wisby, CEO of Oxford Quantum Circuits

Read more

The genome only makes sense in 3D, by Lachlan Mackinnon

Read more

Orca Computing raises £2.9m in pre-seed funding for photonics quantum computer

Read more

Positive Phase 1 readout of Dr Sarah Gilbert covid vaccine

Read more

Cybersecurity in the age of quantum: Our investment in PQShield

Read more

Evox announces landmark partnerships with pharma giants Takeda and Eli Lilly

Read more

Welcome to the portfolio, Base Genomics!

Read more

A royal launch of our Grassroots incubator space!

Read more

Uciane Scarlett, our Life Sciences principal, on an inclusive biotech sector

Read more

Vaccitech CEO Bill Enright on the Oxford Covid-19 vaccine

Read more

Ultromics featured in the Wall Street Journal

Read more

Introducing the Scientist in Residence

Read more

Quantum Motion raises £8m in an oversubscribed Series A led by Inkef Capital

Read more

Vaccitech partners with the University of Oxford and AstraZeneca to develop a Covid-19 vaccine

Read more

Huma Health (formerly Medopad) acquires Biobeats to develop their mental health capabilities

Read more

Niantic acquires 6D.ai to develop their augmented reality platform

Read more

Congratulations OMass! Team raises £27.5m in additional Series A funding

Read more

Patrick Pichette to step down from OSI board, Chris Chambers announced as new chair

Read more

Latent Logic acquired by Waymo. Congratulations to the team!

Read more

MiroBio launches with £27m Series A!

Read more

Ten tools every developer should know in 2018 [Diffblue]

Read more

Genomics raises £25m as it announces deal with US pharma giant

Read more

10 outstanding start-ups from Oxford to watch

Read more

15 Machine Learning Companies To Watch In Europe

Read more

Navenio raises £9m for its hospital workforce AI platform

Read more

NHS to trial Uber-style location service to match up patients, porters and equipment

Read more

Twitter

Our portfolio company Quantum Motion are in Forbes!

#quantum #oxfordscience #breakthrough

https://www.forbes.com/sites/adrianbridgwater/2021/05/13/uk-firm-proves-quantum-capability-on-commercial-silicon-chips/?sh=44a5eea4d115

Engineers, scientists, researchers, technicians. Dog or cat person, we don’t mind. If you’re a meat lover, passionate about biotechnology and compassionate about animals and the planet, see what roles we’re currently hiring for and join the herd.

http://www.ivy.farm/careers

Thank you to the UK media outlets for sharing our mission today. We’ll let you all know when we’re ready to fire up the BBQ. - Russ (aka The Hog Father)

@thetimes @dailymailuk, @thesun, @dailymirror, @BBC, @BBCRadio4.

#media #biotechnology #culturedmeat

Stay up to date

Get the latest on cutting-edge developments in our portfolio, straight to your inbox.